MedPath

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
Registration Number
NCT00005832
Lead Sponsor
SWOG Cancer Research Network
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of R115777 in treating patients who have locally advanced or metastatic pancreatic cancer.

Detailed Description

OBJECTIVES: I. Determine the six month survival rate in patients with advanced adenocarcinoma of the pancreas treated with R115777. II. Determine the time to treatment failure and confirmed response in this patient population treated with this regimen. III. Evaluate the frequency and severity of toxicities associated with this treatment regimen in these patients.

OUTLINE: Patients receive oral R115777 twice daily on days 1-21. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity. Patients are followed every 6 months for 2 years and then annually thereafter.

PROJECTED ACCRUAL: A total of 21-50 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
R115777R115777300mg/dose BID, PO, Days 1-21, q 28days
Primary Outcome Measures
NameTimeMethod
Survival rate in patients with advanced adenocarcinoma of the pancreas treated with R1157776 months
Secondary Outcome Measures
NameTimeMethod
Evaluate the frequency and severity of toxicitiesWeekly for 8 weeks and then once every 4 weeks
Assess confirmed response (complete & partial) in patients with measurable advanced adenocarcinoma of the pancreasOnce every 8 weeks
Time to treatment failureOnce every 8 weeks until progression

Trial Locations

Locations (14)

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

CCOP - Columbus

🇺🇸

Columbus, Ohio, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

USC/Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

Veterans Affairs Outpatient Clinic - Martinez

🇺🇸

Martinez, California, United States

CCOP - Central Illinois

🇺🇸

Decatur, Illinois, United States

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

Veterans Affairs Medical Center - Wichita

🇺🇸

Wichita, Kansas, United States

CCOP - Kansas City

🇺🇸

Kansas City, Missouri, United States

CCOP - Greenville

🇺🇸

Greenville, South Carolina, United States

University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

CCOP - Virginia Mason Research Center

🇺🇸

Seattle, Washington, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath